Privia Health Group, Inc. Operating Income
Privia Health Group, Inc. (PRVA) reported Operating Income of $11.77 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-06
- Privia Health Group, Inc. operating income (loss) for the quarter ending 2026-06-30 was $11.77M, a 252.91% increase year-over-year.
- Privia Health Group, Inc. operating income (loss) for the quarter ending 2026-03-31 was $7.42M, a 42.24% increase year-over-year.
- Privia Health Group, Inc. operating income (loss) for the quarter ending 2025-12-31 was $11.28M, a 114.90% increase year-over-year.
- Privia Health Group, Inc. operating income (loss) for the quarter ending 2025-09-30 was $14.40M, a 147.77% increase year-over-year.
- Privia Health Group, Inc. operating income (loss) for fiscal 2025 was $34.23M, a 101.60% increase from fiscal 2024.
- Privia Health Group, Inc. operating income (loss) for fiscal 2024 was $16.98M, a 17.76% decline from fiscal 2023.
- Privia Health Group, Inc. operating income (loss) for fiscal 2023 was $20.65M.
- Privia Health Group, Inc. operating income (loss) for fiscal 2022 was -$19.12M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $11.77M 10-Q · filed 2026-08-06 | $19.20M 10-Q · filed 2026-08-06 | $30.47M derived: sum of 3 quarters · filed 2026-08-06 | $44.88M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $7.42M 10-Q · filed 2026-05-07 | $18.70M derived: sum of 2 quarters · filed 2026-05-07 | $33.10M derived: sum of 3 quarters · filed 2026-05-07 | $36.44M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $11.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $25.68M derived: sum of 2 quarters · filed 2026-02-27 | $29.02M derived: sum of 3 quarters · filed 2026-08-06 | $34.23M 10-K · filed 2026-02-27 |
| 2025-09-30 | $14.40M 10-Q · filed 2025-11-06 | $17.74M derived: sum of 2 quarters · filed 2026-08-06 | $22.96M 10-Q · filed 2025-11-06 | $28.20M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $3.34M 10-Q · filed 2026-08-06 | $8.55M 10-Q · filed 2026-08-06 | $13.80M derived: sum of 3 quarters · filed 2026-08-06 | $19.61M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $5.22M 10-Q · filed 2026-05-07 | $10.47M derived: sum of 2 quarters · filed 2026-05-07 | $16.28M derived: sum of 3 quarters · filed 2026-05-07 | $21.38M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $5.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $11.06M derived: sum of 2 quarters · filed 2026-02-27 | $16.16M derived: sum of 3 quarters · filed 2026-02-27 | $16.98M 10-K · filed 2026-02-27 |
| 2024-09-30 | $5.81M 10-Q · filed 2025-11-06 | $10.91M derived: sum of 2 quarters · filed 2025-11-06 | $11.73M 10-Q · filed 2025-11-06 | $13.15M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $5.10M 10-Q · filed 2025-08-07 | $5.92M 10-Q · filed 2025-08-07 | $7.34M derived: sum of 3 quarters · filed 2026-02-27 | $12.88M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $823.00K 10-Q · filed 2025-05-08 | $2.24M derived: sum of 2 quarters · filed 2026-02-27 | $7.78M derived: sum of 3 quarters · filed 2026-02-27 | $14.76M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $6.96M derived: sum of 2 quarters · filed 2026-02-27 | $13.94M derived: sum of 3 quarters · filed 2026-02-27 | $20.65M 10-K · filed 2026-02-27 |
| 2023-09-30 | $5.54M 10-Q · filed 2024-11-07 | $12.52M derived: sum of 2 quarters · filed 2024-11-07 | $19.23M 10-Q · filed 2024-11-07 | $21.48M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $6.98M 10-Q · filed 2024-08-08 | $13.69M 10-Q · filed 2024-08-08 | $15.94M derived: sum of 3 quarters · filed 2025-02-27 | $11.37M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $6.71M 10-Q · filed 2024-05-09 | $8.96M derived: sum of 2 quarters · filed 2025-02-27 | $4.39M derived: sum of 3 quarters · filed 2025-02-27 | -$861.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$2.33M derived: sum of 2 quarters · filed 2025-02-27 | -$7.58M derived: sum of 3 quarters · filed 2025-02-27 | -$19.12M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$4.57M 10-Q · filed 2023-11-03 | -$9.82M derived: sum of 2 quarters · filed 2023-11-03 | -$21.37M 10-Q · filed 2023-11-03 | -$40.72M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | -$5.25M 10-Q · filed 2023-08-03 | -$16.80M 10-Q · filed 2023-08-03 | -$36.14M derived: sum of 3 quarters · filed 2024-02-27 | -$48.95M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | -$11.55M 10-Q · filed 2023-05-04 | -$30.89M derived: sum of 2 quarters · filed 2024-02-27 | -$43.70M derived: sum of 3 quarters · filed 2024-02-27 | -$236.89M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | -$19.35M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$32.16M derived: sum of 2 quarters · filed 2024-02-27 | -$225.34M derived: sum of 3 quarters · filed 2024-02-27 | -$217.44M 10-K · filed 2024-02-27 |
| 2021-09-30 | -$12.81M 10-Q · filed 2022-11-10 | -$206.00M derived: sum of 2 quarters · filed 2022-11-10 | -$198.09M 10-Q · filed 2022-11-10 | -$193.93M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | -$193.19M 10-Q · filed 2022-08-11 | -$185.28M 10-Q · filed 2022-08-11 | -$181.12M derived: sum of 3 quarters · filed 2023-03-01 | -$172.57M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $7.91M 10-Q · filed 2022-05-12 | $12.07M derived: sum of 2 quarters · filed 2023-03-01 | $20.61M derived: sum of 3 quarters · filed 2023-03-01 | $26.79M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $4.16M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $12.71M derived: sum of 2 quarters · filed 2023-03-01 | $18.88M derived: sum of 3 quarters · filed 2023-03-01 | $25.38M 10-K · filed 2023-03-01 |
| 2020-09-30 | $8.54M 10-Q · filed 2021-11-08 | $14.72M derived: sum of 2 quarters · filed 2021-11-08 | $21.22M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $6.18M 10-Q · filed 2021-08-09 | $12.68M 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | $6.50M 10-Q · filed 2021-05-28 | |||
| 2019-12-31 | $16.06M 10-K · filed 2022-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |